MAPT and Alzheimer disease: Complementing these studies, we have noted changes in AD-related synaptic gene expression signatures in xenografted APPV717I neurons 2 months after cell injection, and we have identified neuronal cell loss, neurite outgrowth deficits and p-tau pathology in APPV717I neurons 12 months post-injection.